Deep learning and radiomics fusion for predicting the invasiveness of lung adenocarcinoma within ground glass nodules.
Journal:
Scientific reports
Published Date:
Aug 11, 2025
Abstract
Microinvasive adenocarcinoma (MIA) and invasive adenocarcinoma (IAC) require distinct treatment strategies and are associated with different prognoses, underscoring the importance of accurate differentiation. This study aims to develop a predictive model that combines radiomics and deep learning to effectively distinguish between MIA and IAC. In this retrospective study, 252 pathologically confirmed cases of ground-glass nodules (GGNs) were included, with 177 allocated to the training set and 75 to the testing set. Radiomics, 2D deep learning, and 3D deep learning models were constructed based on CT images. In addition, two fusion strategies were employed to integrate these modalities: early fusion, which concatenates features from all modalities prior to classification, and late fusion, which ensembles the output probabilities of the individual models. The predictive performance of all five models was evaluated using the area under the receiver operating characteristic curve (AUC), and DeLong's test was performed to compare differences in AUC between models. The radiomics model achieved an AUC of 0.794 (95% CI: 0.684-0.898), while the 2D and 3D deep learning models achieved AUCs of 0.754 (95% CI: 0.594-0.882) and 0.847 (95% CI: 0.724-0.945), respectively, in the testing set. Among the fusion models, the late fusion strategy demonstrated the highest predictive performance, with an AUC of 0.898 (95% CI: 0.784-0.962), outperforming the early fusion model, which achieved an AUC of 0.857 (95% CI: 0.731-0.936). Although the differences were not statistically significant, the late fusion model yielded the highest numerical values for diagnostic accuracy, sensitivity, and specificity across all models. The fusion of radiomics and deep learning features shows potential in improving the differentiation of MIA and IAC in GGNs. The late fusion strategy demonstrated promising results, warranting further validation in larger, multicenter studies.
